Monday 16 June 2014 4:02pm
Centre for Translational Cancer Research investigators feature in HRC funding awarded in both project grants and emerging researcher categories.
We're delighted that HRC has recognised the research contribution of both established expertise and the talent of emerging researchers associated with the Centre.
Emerging Researcher First Grants recipients
New technology in tumour-targeted chemotherapy
Treating advanced rectal cancer
Project Grants
A role for p53 isoforms in inflammatory disease
Professor Antony Braithwaite, lead investigator
Professor Margaret Baird, named investigator
Read about a related project:
Role of p53 isoforms in cancer and inflammation
An epigenome-wide study for abdominal aortic aneurysm
Professor Ian Morison, named investigator
Genetics, brain imaging, and cognitive decline in Parkinson's disease
Professor Martin Kennedy, named investigator
Read the full University of Otago media release:
Major funding for innovative health research 9 June 2014, University of Otago website
Related HRC funding success:
Innovative Otago breast cancer research gains HRC support
